Document Type

Article

Journal Title

Clinical Ophthalmology

Publication Date

Fall 9-22-2014

Volume

8

Abstract

Uveitis, a group of conditions characterized by intraocular inflammation, is a major cause of sight loss in the working population. Most uveitis seen in Western countries is noninfectious and appears to be autoimmune or autoinflammatory in nature, requiring treatment with immunosuppressive and/or anti-inflammatory drugs. In this educational review, we outline the ideal characteristics of drugs for uveitis and review the data to support the use of current and emerging therapies in this context. It is crucial that we continue to develop new therapies for use in uveitis that aim to suppress disease activity, prevent accumulation of damage, and preserve visual function for patients with the minimum possible side effects.

ISSN

1177-5467

Creative Commons License


This work is licensed under a Creative Commons Attribution-Noncommercial 3.0 License

Included in

Ophthalmology Commons

Share

COinS